Literature DB >> 29216444

Under Pressure to Clarify Pulmonary Hypertension Clinical Risk.

Bradley A Maron1,2, Bradley M Wertheim3, Mark T Gladwin4,5.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29216444      PMCID： PMC5821912          DOI： 10.1164/rccm.201711-2306ED

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   30.528


× No keyword cloud information.
  22 in total

1.  Haematological determinants of cardiac involvement in adults with sickle cell disease.

Authors:  Thibaud Damy; Diane Bodez; Anoosha Habibi; Aziz Guellich; Stéphane Rappeneau; Jocelyn Inamo; Soulef Guendouz; Justine Gellen-Dautremer; Serge Pissard; Sylvain Loric; Orianne Wagner-Ballon; Bertrand Godeau; Serge Adnot; Jean-Luc Dubois-Randé; Luc Hittinger; Frédéric Galactéros; Pablo Bartolucci
Journal:  Eur Heart J       Date:  2015-10-29       Impact factor: 29.983

2.  Proposed new definition of exercise pulmonary hypertension decreases false-positive cases.

Authors:  Gabor Kovacs; Alexander Avian; Horst Olschewski
Journal:  Eur Respir J       Date:  2016-01-07       Impact factor: 16.671

Review 3.  Translational Advances in the Field of Pulmonary Hypertension. Focusing on Developmental Origins and Disease Inception for the Prevention of Pulmonary Hypertension.

Authors:  Bradley A Maron; Steven H Abman
Journal:  Am J Respir Crit Care Med       Date:  2017-02-01       Impact factor: 21.405

4.  Clinical characterization and survival of patients with borderline elevation in pulmonary artery pressure.

Authors:  Gustavo A Heresi; Omar A Minai; Adriano R Tonelli; Jeffrey P Hammel; Samar Farha; Joseph G Parambil; Raed A Dweik
Journal:  Pulm Circ       Date:  2013-12       Impact factor: 3.017

Review 5.  Definitions and diagnosis of pulmonary hypertension.

Authors:  Marius M Hoeper; Harm Jan Bogaard; Robin Condliffe; Robert Frantz; Dinesh Khanna; Marcin Kurzyna; David Langleben; Alessandra Manes; Toru Satoh; Fernando Torres; Martin R Wilkins; David B Badesch
Journal:  J Am Coll Cardiol       Date:  2013-12-24       Impact factor: 24.094

6.  Redefining pulmonary hypertension.

Authors:  Bradley A Maron; Evan L Brittain; Gaurav Choudhary; Mark T Gladwin
Journal:  Lancet Respir Med       Date:  2017-12-18       Impact factor: 30.700

7.  Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.

Authors:  Bradley A Maron; Edward Hess; Thomas M Maddox; Alexander R Opotowsky; Ryan J Tedford; Tim Lahm; Karen E Joynt; Daniel J Kass; Thomas Stephens; Maggie A Stanislawski; Erik R Swenson; Ronald H Goldstein; Jane A Leopold; Roham T Zamanian; Jean M Elwing; Mary E Plomondon; Gary K Grunwald; Anna E Barón; John S Rumsfeld; Gaurav Choudhary
Journal:  Circulation       Date:  2016-02-12       Impact factor: 29.690

8.  Resting pulmonary artery pressure of 21-24 mmHg predicts abnormal exercise haemodynamics.

Authors:  Edmund M T Lau; Laurent Godinas; Olivier Sitbon; David Montani; Laurent Savale; Xavier Jaïs; Frederic Lador; Sven Gunther; David S Celermajer; Gérald Simonneau; Marc Humbert; Denis Chemla; Philippe Herve
Journal:  Eur Respir J       Date:  2016-03-10       Impact factor: 16.671

9.  Pulmonary hypertension as a prognostic indicator at the initial evaluation in idiopathic pulmonary fibrosis.

Authors:  Motohiro Kimura; Hiroyuki Taniguchi; Yasuhiro Kondoh; Tomoki Kimura; Kensuke Kataoka; Osamu Nishiyama; Hiromichi Aso; Koji Sakamoto; Yoshinori Hasegawa
Journal:  Respiration       Date:  2012-12-19       Impact factor: 3.580

10.  Age-associated increases in pulmonary artery systolic pressure in the general population.

Authors:  Carolyn S P Lam; Barry A Borlaug; Garvan C Kane; Felicity T Enders; Richard J Rodeheffer; Margaret M Redfield
Journal:  Circulation       Date:  2009-05-11       Impact factor: 29.690
View more
  5 in total

Review 1.  Pathophysiology of Sickle Cell Disease.

Authors:  Prithu Sundd; Mark T Gladwin; Enrico M Novelli
Journal:  Annu Rev Pathol       Date:  2018-10-17       Impact factor: 23.472

2.  Update in Pulmonary Vascular Diseases and Right Ventricular Dysfunction 2019.

Authors:  Elena A Goncharova; Stephen Y Chan; Corey E Ventetuolo; Norbert Weissmann; Ralph T Schermuly; Christopher J Mullin; Mark T Gladwin
Journal:  Am J Respir Crit Care Med       Date:  2020-07-01       Impact factor: 21.405

3.  Sexual Dimorphism of Dexamethasone as a Prophylactic Treatment in Pathologies Associated With Acute Hypobaric Hypoxia Exposure.

Authors:  Neha Chanana; Tsering Palmo; Kavita Sharma; Rahul Kumar; Bhushan Shah; Sudhanshu Mahajan; Girish M Palleda; Mohit D Gupta; Ritushree Kukreti; Mohammad Faruq; Tashi Thinlas; Brian B Graham; Qadar Pasha
Journal:  Front Pharmacol       Date:  2022-05-20       Impact factor: 5.988

4.  Haemodynamic definitions and updated clinical classification of pulmonary hypertension.

Authors:  Gérald Simonneau; David Montani; David S Celermajer; Christopher P Denton; Michael A Gatzoulis; Michael Krowka; Paul G Williams; Rogerio Souza
Journal:  Eur Respir J       Date:  2019-01-24       Impact factor: 16.671

5.  Pulmonary Hypertension in Patients with Heart Failure with Preserved Ejection Fraction. Where to Draw the Line.

Authors:  Marc A Simon; Bradley A Maron
Journal:  Am J Respir Crit Care Med       Date:  2019-08-01       Impact factor: 21.405
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.